Study how serotonin signals work in inflammatory bowel disease
Part of Digestive system clinical trials.
This study looks at how the body’s serotonin system behaves in people with Crohn’s disease or ulcerative colitis, compared with healthy people. It may help researchers understand disease biology and why symptoms can differ from person to person.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have Crohn’s disease or ulcerative colitis (IBD)
- You must share details about when your disease started and how it has changed over time
- You must report what treatments you’ve used before and any treatment you’re currently taking
- If you’re a healthy control, you must not have Crohn’s, ulcerative colitis, or IBS
- You should not be using medicines that directly affect serotonin signaling
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects blood and tissue samples to better understand how the immune system behaves in people with inflammatory bowel disease (IBD), which includes Crohn's disease and ulcerative colitis. It aims to advance research rather than test a specific new treatment, and it also enrolls healthy volunteers for comparison.
This study is looking at how the immune system works in people with inflammatory bowel disease (IBD), which includes conditions like Crohn's disease and ulcerative colitis. By comparing blood or tissue samples from people with and without IBD, researchers hope to find better ways to treat the disease in the future.
This trial studies whether eating a Mediterranean-style diet can improve inflammatory bowel disease (including mild to moderate Crohn’s). It may help by testing changes in gut inflammation measured by your symptoms and stool tests.
This study looks at blood and/or tissue “molecular” (cell-level) reasons why treatments don’t fully work in adults with Crohn’s disease or ulcerative colitis. If you are starting a biologic or small-molecule medicine and still have moderate to severe symptoms, you may be able to contribute to research that helps improve future care.
This study looks at people with inflammatory bowel disease (Crohn’s disease or ulcerative colitis) and compares them with people without it. Researchers want to understand differences that may help explain or better detect the disease.
This study looks at how changes in gut bacteria (the microbiome) relate to inflammatory bowel disease, including ulcerative colitis and Crohn disease. It may help researchers understand what might improve symptoms or disease control.
Hear when a new Inflammatory Bowel Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.